{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:39:38Z","timestamp":1792586378026,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,21]],"date-time":"2027-04-21T00:00:00Z","timestamp":1808265600000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DA042985"],"award-info":[{"award-number":["R01-DA042985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DA14211"],"award-info":[{"award-number":["R01-DA14211"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24-DA00417"],"award-info":[{"award-number":["K24-DA00417"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1-TR000448"],"award-info":[{"award-number":["UL1-TR000448"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bja.2025.11.060","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:14:34Z","timestamp":1770466474000},"page":"1459-1471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Morphine and hydromorphone pharmacodynamics in human volunteers: population-based modelling of interindividual response variability and utility"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5709-2063","authenticated-orcid":false,"given":"Erik","family":"Olofsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9960-5453","authenticated-orcid":false,"given":"Konrad","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-3945","authenticated-orcid":false,"given":"Albert","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-922X","authenticated-orcid":false,"given":"Evan D.","family":"Kharasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2025.11.060_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/ACO.0000000000001529","article-title":"The future of target-controlled infusion and new pharmacokinetic models","volume":"38","author":"Absalom","year":"2025","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.bja.2025.11.060_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1742-7843.2011.00814.x","article-title":"Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireview","volume":"110","author":"Ing-Lorenzini","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.bja.2025.11.060_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2125.2012.04317.x","article-title":"Differences between opioids: pharmacological, experimental, clinical and economical perspectives","volume":"75","author":"Drewes","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bja.2025.11.060_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.36076\/ppj.2024.7.469","article-title":"Effectiveness and safety of hydromorphone compared to morphine for postoperative analgesia: a systematic review and meta-analysis","volume":"27","author":"Li","year":"2024","journal-title":"Pain Physician"},{"key":"10.1016\/j.bja.2025.11.060_bib5","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.jpainsymman.2005.01.012","article-title":"Pharmacokinetic-pharmacodynamic modeling of opioids","volume":"29","author":"L\u00f6tsch","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.bja.2025.11.060_bib6","first-page":"e538","article-title":"Comparative efficacy of opioids for older adults presenting to the emergency department with acute pain: systematic review","volume":"65","author":"de Vries","year":"2019","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.bja.2025.11.060_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/bja\/aer232","article-title":"Comparative clinical effects of hydromorphone and morphine: a meta-analysis","volume":"107","author":"Felden","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.060_bib8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/archdischild-2020-319059","article-title":"Morphine or hydromorphone: which should be preferred? A systematic review","volume":"106","author":"Sp\u00e9nard","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.bja.2025.11.060_bib9","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1213\/ANE.0000000000005413","article-title":"Opioid-induced respiratory depression: Is hydromorphone safer than morphine?","volume":"132","author":"Roth","year":"2021","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.11.060_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ALN.0000000000004567","article-title":"Morphine and hydromorphone effects, side effects, and variability: a crossover study in human volunteers","volume":"139","author":"Meissner","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.060_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bja.2024.08.042","article-title":"Morphine and hydromorphone pharmacokinetics in human volunteers: population-based modelling of interindividual and opioid-related variability","volume":"134","author":"Meissner","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.060_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13318-015-0318-x","article-title":"External validation of a recently developed population pharmacokinetic model for hydromorphone during postoperative pain therapy","volume":"42","author":"Ihmsen","year":"2017","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bja.2025.11.060_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/ALN.0b013e3182a76d05","article-title":"Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy","volume":"120","author":"Jeleazcov","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.060_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-012-9282-0","article-title":"Translational PK-PD modeling in pain","volume":"40","author":"Yassen","year":"2013","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.bja.2025.11.060_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106520","article-title":"A biomarker of opioid-induced respiratory toxicity in experimental studies","volume":"26","author":"Hellinga","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.bja.2025.11.060_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/ALN.0000000000005710","article-title":"Fentanyl-induced ventilatory depression: population pharmacokinetic\/ pharmacodynamic framework for evaluation of opioid-induced ventilatory depression","volume":"143","author":"van Lemmen","year":"2025","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.060_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/ALN.0b013e31829ce4cb","article-title":"Fentanyl utility function: a risk-benefit composite of pain relief and breathing responses","volume":"119","author":"Boom","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.060_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0304-3959(89)90240-6","article-title":"Measurements of human pressure-pain thresholds on fingers and toes","volume":"38","author":"Brennum","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.bja.2025.11.060_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/ALN.0000000000000937","article-title":"Patient-controlled analgesia with target-controlled infusion of hydromorphone in postoperative pain therapy","volume":"124","author":"Jeleazcov","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.060_bib20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000542-200411000-00021","article-title":"Simultaneous measurement and integrated analysis of analgesia and respiration after an intravenous morphine infusion","volume":"101","author":"Dahan","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.060_bib21","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14656566.9.11.1955","article-title":"Morphine-6-glucuronide: potency and safety compared with morphine","volume":"9","author":"van Dorp","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bja.2025.11.060_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12630-020-01849-4","article-title":"Hydromorphone versus morphine: a historical cohort study to evaluate the quality of postoperative analgesia","volume":"68","author":"Rodrigues","year":"2021","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2025.11.060_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000500","article-title":"Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers","volume":"152","author":"Hill","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bja.2025.11.060_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3959(97)00018-3","article-title":"Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study","volume":"72","author":"Lawlor","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.bja.2025.11.060_bib25","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1213\/ane.0b013e3181823efb","article-title":"The side effects of morphine and hydromorphone patient-controlled analgesia","volume":"107","author":"Hong","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.11.060_bib26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1213\/ANE.0000000000001229","article-title":"Intrathecal hydromorphone and morphine for postcesarean delivery analgesia: determination of the ed90 using a sequential allocation biased-coin method","volume":"123","author":"Sviggum","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.11.060_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12871-024-02420-0","article-title":"The 50% effective dose of hydromorphone and morphine for epidural analgesia in the hemorrhoidectomy: a double-blind, sequential dose-finding study","volume":"24","author":"Cao","year":"2024","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.bja.2025.11.060_bib28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bja.2022.08.026","article-title":"Remifentanil pharmacodynamics during conscious sedation using algometry: a more clinically relevant pharmacodynamical model","volume":"129","author":"Abad-Torrent","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.060_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1060028015625659","article-title":"Opioid pharmacokinetics-pharmacodynamics: clinical implications in acute pain management in trauma","volume":"50","author":"MacKenzie","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.bja.2025.11.060_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1067\/mcp.2003.5","article-title":"Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers","volume":"73","author":"Skarke","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2025.11.060_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1213\/01.ane.0000265557.73688.32","article-title":"Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites","volume":"105","author":"Mazoit","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.11.060_bib32","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/ALN.0b013e3181d5e29d","article-title":"Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study","volume":"112","author":"Olofsen","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.060_bib33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000542-200009000-00009","article-title":"Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers","volume":"93","author":"Dershwitz","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.060_bib34","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000542-200112000-00009","article-title":"The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers","volume":"95","author":"L\u00f6tsch","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.060_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00000542-200101000-00014","article-title":"Pharmacodynamics of orally administered sustained-release hydromorphone in humans","volume":"94","author":"Angst","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.060_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1067\/mcp.2003.30","article-title":"Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity","volume":"73","author":"Kharasch","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2025.11.060_bib37","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0091270005280077","article-title":"Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity","volume":"45","author":"Kharasch","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bja.2025.11.060_bib38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bja.2024.09.020","article-title":"Comparison of different monitors for measurement of nociception during general anaesthesia: a network meta-analysis of randomised controlled trials","volume":"134","author":"Snoek","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.060_bib39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.118.253716","article-title":"A pragmatic utility function to describe the risk-benefit composite of opioid and nonopioid analgesic medication","volume":"371","author":"Olesen","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bja.2025.11.060_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00003088-199834040-00005","article-title":"Predicting effective drug concentrations for individual patients. Determinants of pharmacodynamic variability","volume":"34","author":"Levy","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2025.11.060_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0169-409X(98)00028-3","article-title":"Impact of pharmacodynamic variability on drug delivery","volume":"33","author":"Levy","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bja.2025.11.060_bib42","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/cpt.3197","article-title":"Beyond population-level targets for drug concentrations: precision dosing needs individual-level targets that include superior biomarkers of drug responses","volume":"116","author":"Polasek","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2025.11.060_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0009-9236(96)90210-6","article-title":"Population pharmacodynamic model for ketorolac analgesia","volume":"60","author":"Mandema","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2025.11.060_bib44","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0149-2918(00)83043-X","article-title":"Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic\/pharmacodynamic profiles of zaleplon and zolpidem","volume":"22","author":"Drover","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.bja.2025.11.060_bib45","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1213\/ANE.0000000000005125","article-title":"Relationship between propofol target concentrations, bispectral index, and patient covariates during anesthesia","volume":"132","author":"Schnider","year":"2021","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.11.060_bib46","first-page":"3936","article-title":"Inter-individual variability in propofol pharmacokinetic\/pharmacodynamic (PK\/PD) model \u2013 a sensitivity analysis","volume":"4","author":"Chang","year":"2016","journal-title":"Sch J App Med Sci"},{"key":"10.1016\/j.bja.2025.11.060_bib47","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10877-020-00581-0","article-title":"Multi-model generalised predictive control for intravenous anaesthesia under inter-individual variability","volume":"35","author":"Jing","year":"2021","journal-title":"J Clin Monit Comput"},{"key":"10.1016\/j.bja.2025.11.060_bib48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.bja.2023.06.064","article-title":"Variability of predicted propofol concentrations and measured sevoflurane concentrations during general anaesthesia: a single-centre retrospective cohort study","volume":"131","author":"Schnider","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.060_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1109\/TBME.2013.2274816","article-title":"Modeling and analysis of individualized pharmacokinetics and pharmacodynamics for volatile anesthesia","volume":"61","author":"Krieger","year":"2014","journal-title":"IEEE Trans Biomed Eng"}],"updated-by":[{"DOI":"10.1016\/j.bja.2026.04.044","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000}},{"DOI":"10.1016\/j.bja.2026.04.044","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225009134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225009134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:51:36Z","timestamp":1778719896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091225009134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0007091225009134"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2025.11.060","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphine and hydromorphone pharmacodynamics in human volunteers: population-based modelling of interindividual response variability and utility","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.11.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}